SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 26.74+1.6%1:40 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: aknahow who wrote (10261)5/28/1999 10:00:00 PM
From: Cacaito  Read Replies (2) of 17367
 
From old wohanka files: www3.techstocks.com

How did you get to 33? is any p value available on this?

My numbers were 47 mid estimate, 42 the lowest (forget the highest).

I still have to crunch couple of numbers, maybe the statistics to design the trial are much more complex than what I thought for the mortality data.

Nice finding on Otitis Media, quite interesting.
Is it Xoma sponsored? Are authors related to Xoma?

Probably is for chronic Otitis media with perforation and or timpanostomy tubes. Not for the common acute phases. Still a huge market. New improved pneumococus vaccine will thankfully decrease that market significantly ( expected decrease 50%, more for the chronic ones).

It will most probably be a topical treatment directly to the local problem, i.e. the ears.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext